219 related articles for article (PubMed ID: 32999412)
1. Involvement of the secreted protein Metrnl in human diseases.
Miao ZW; Hu WJ; Li ZY; Miao CY
Acta Pharmacol Sin; 2020 Dec; 41(12):1525-1530. PubMed ID: 32999412
[TBL] [Abstract][Full Text] [Related]
2. Meteorin-like protein (Metrnl): A metabolic syndrome biomarker and an exercise mediator.
Alizadeh H
Cytokine; 2022 Sep; 157():155952. PubMed ID: 35780711
[TBL] [Abstract][Full Text] [Related]
3. Metrnl: a secreted protein with new emerging functions.
Zheng SL; Li ZY; Song J; Liu JM; Miao CY
Acta Pharmacol Sin; 2016 May; 37(5):571-9. PubMed ID: 27063217
[TBL] [Abstract][Full Text] [Related]
4. The Function and Mechanism of Anti-Inflammatory Factor Metrnl Prevents the Progression of Inflammatory-Mediated Pathological Bone Osteolytic Diseases.
Liu N; Dong J; Li L; Zhou D; Liu F
J Inflamm Res; 2024; 17():1607-1619. PubMed ID: 38495340
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte Metrnl Antagonizes Insulin Resistance Through PPARγ Signaling.
Li ZY; Song J; Zheng SL; Fan MB; Guan YF; Qu Y; Xu J; Wang P; Miao CY
Diabetes; 2015 Dec; 64(12):4011-22. PubMed ID: 26307585
[TBL] [Abstract][Full Text] [Related]
6. Meteorin-like/Metrnl, a novel secreted protein implicated in inflammation, immunology, and metabolism: A comprehensive review of preclinical and clinical studies.
Li Z; Gao Z; Sun T; Zhang S; Yang S; Zheng M; Shen H
Front Immunol; 2023; 14():1098570. PubMed ID: 36911663
[TBL] [Abstract][Full Text] [Related]
7. Myokine-mediated exercise effects: the role of myokine meteorin-like hormone (Metrnl).
Alizadeh H
Growth Factors; 2021; 39(1-6):71-78. PubMed ID: 35133923
[TBL] [Abstract][Full Text] [Related]
8. METRNL decreases during adipogenesis and inhibits adipocyte differentiation leading to adipocyte hypertrophy in humans.
Löffler D; Landgraf K; Rockstroh D; Schwartze JT; Dunzendorfer H; Kiess W; Körner A
Int J Obes (Lond); 2017 Jan; 41(1):112-119. PubMed ID: 27748745
[TBL] [Abstract][Full Text] [Related]
9. Serum Metrnl Level is Correlated with Insulin Resistance, But Not with β-Cell Function in Type 2 Diabetics.
Wang C; Pan Y; Song J; Sun Y; Li H; Chen L; Hou X
Med Sci Monit; 2019 Nov; 25():8968-8974. PubMed ID: 31766048
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Metrnl released into the gut lumen acts as a local regulator for gut antimicrobial peptides.
Li ZY; Fan MB; Zhang SL; Qu Y; Zheng SL; Song J; Miao CY
Acta Pharmacol Sin; 2016 Nov; 37(11):1458-1466. PubMed ID: 27546006
[TBL] [Abstract][Full Text] [Related]
11. Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes.
Chung HS; Hwang SY; Choi JH; Lee HJ; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM
Diabetes Res Clin Pract; 2018 Feb; 136():100-107. PubMed ID: 29199003
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of the relationship between serums metrnl-like protein/subfatin and risk of type 2 diabetes mellitus and coronary artery disease.
Ferns GA; Fekri K; Shahini Shams Abadi M; Banitalebi Dehkordi M; Arjmand MH
Arch Physiol Biochem; 2023 Oct; 129(5):1084-1090. PubMed ID: 33950769
[TBL] [Abstract][Full Text] [Related]
13. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.
Dadmanesh M; Aghajani H; Fadaei R; Ghorban K
PLoS One; 2018; 13(9):e0204180. PubMed ID: 30212581
[TBL] [Abstract][Full Text] [Related]
14. The Adipokine Metrnl Ameliorates Chronic Colitis in Il-10-/- Mice by Attenuating Mesenteric Adipose Tissue Lesions During Spontaneous Colitis.
Zuo L; Ge S; Ge Y; Li J; Zhu B; Zhang Z; Jiang C; Li J; Wang S; Liu M; Li S; Wu R; Hu J
J Crohns Colitis; 2019 Jul; 13(7):931-941. PubMed ID: 30615095
[TBL] [Abstract][Full Text] [Related]
15. Low serum levels of meteorin-like/subfatin: an indicator of diabetes mellitus and insulin resistance?
Onalan E; Cavlı C; Dogan Y; Onalan E; Gozel N; Buran I; Yakar B; Donder E
Endokrynol Pol; 2020; 71(5):397-403. PubMed ID: 32598020
[TBL] [Abstract][Full Text] [Related]
16. Serum Metrnl levels are decreased in subjects with overweight or obesity and are independently associated with adverse lipid profile.
Ding X; Chang X; Wang J; Bian N; An Y; Wang G; Liu J
Front Endocrinol (Lausanne); 2022; 13():938341. PubMed ID: 36133314
[TBL] [Abstract][Full Text] [Related]
17. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice.
Jung TW; Lee SH; Kim HC; Bang JS; Abd El-Aty AM; Hacımüftüoğlu A; Shin YK; Jeong JH
Exp Mol Med; 2018 Sep; 50(9):1-11. PubMed ID: 30213948
[TBL] [Abstract][Full Text] [Related]
18. Is Metrnl an Adipokine İnvolved in the Anti-inflammatory Response to Acute Exacerbations of COPD?
Kerget B; Afşin DE; Kerget F; Aşkın S; Akgün M
Lung; 2020 Apr; 198(2):307-314. PubMed ID: 31960164
[TBL] [Abstract][Full Text] [Related]
19. Visfatin/Nampt: an adipokine with cardiovascular impact.
Romacho T; Sánchez-Ferrer CF; Peiró C
Mediators Inflamm; 2013; 2013():946427. PubMed ID: 23843684
[TBL] [Abstract][Full Text] [Related]
20. Association of low serum Meteorin like (Metrnl) concentrations with worsening of glucose tolerance, impaired endothelial function and atherosclerosis.
El-Ashmawy HM; Selim FO; Hosny TAM; Almassry HN
Diabetes Res Clin Pract; 2019 Apr; 150():57-63. PubMed ID: 30825562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
